|
WO2021068898A1
|
|
Novel kras g12c protein inhibitor, preparation method therefor, and use thereof
|
|
WO2021052472A1
|
|
Method for preventing or treating cholesterol-related diseases by using anti-pcsk9 antibody
|
|
WO2021023267A1
|
|
Preparation comprising anti-pd-1/her2 bispecific antibody, and preparation method therefor and use thereof
|
|
WO2021008571A1
|
|
Cell culture method and application thereof based on high-density and continuous inoculation
|
|
WO2020259593A1
|
|
Preparations containing anti-lag-3 antibody, and preparation method therefor and use thereof
|
|
WO2020259605A1
|
|
Formulations containing anti-cd47/pd-l1 bispecific antibody and preparation method therefor and use thereof
|
|
WO2020177719A1
|
|
Yeast display system for displaying and secreting polypeptide of interest and use thereof
|
|
WO2020173431A2
|
|
Preparations containing anti-cd47 antibody, and preparation method and use therefor
|
|
TW202043278A
|
|
Bispecific antibodies that bind to pd-l1 and ox40
|
|
TW202043277A
|
|
Novel bispecific antibody molecules and bispecific antibodies that simultaneously bind pd-l1 and lag-3
|
|
WO2020135426A1
|
|
Fully human anti-cd30 single chain antibodies and use thereof
|
|
WO2020119592A1
|
|
Novel three-ring fused structure compound, preparation method therefor and use thereof
|
|
US2021115130A1
|
|
Anti-il-23p19 antibody and use thereof
|
|
WO2020258706A1
|
|
Combined chromatography apparatus, seamless connection chromatography method, and biological agent purification method
|
|
WO2020258705A1
|
|
Modular chromatography device
|
|
WO2020258704A1
|
|
Seamless continuous flow chromatographic method
|
|
WO2020063668A1
|
|
Formulation containing anti-ox40 antibody, preparation method therefor, and use thereof
|
|
CN112105634A
|
|
Novel interleukin-2 and uses thereof
|
|
CN112105633A
|
|
Novel interleukin-2 and uses thereof
|
|
AU2019310803A1
|
|
Anti-TIGIT antibody and uses thereof
|
